Lonza Group AG (OTCMKTS:LZAGY – Get Free Report)’s stock price reached a new 52-week high on Tuesday . The company traded as high as $67.27 and last traded at $66.94, with a volume of 33104 shares traded. The stock had previously closed at $65.41.
Wall Street Analyst Weigh In
Several analysts have weighed in on LZAGY shares. The Goldman Sachs Group upgraded Lonza Group to a “strong-buy” rating in a research report on Wednesday, October 9th. Redburn Atlantic upgraded shares of Lonza Group to a “strong-buy” rating in a research note on Wednesday, November 27th.
Check Out Our Latest Stock Analysis on LZAGY
Lonza Group Price Performance
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Featured Stories
- Five stocks we like better than Lonza Group
- What is a support level?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- How is Compound Interest Calculated?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.